Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine [Phase 1]
Phase 1 clinical trial update for an orally administered Salmonella-based survivin vaccine in multiple myeloma. The study status is listed a…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Respiatory Viral Infections in Patients With Multiple Myeloma
The study investigating respiratory viral infections in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
Pre-approval single-patient expanded access update for Elranatamab (PF-06863135) in multiple myeloma.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
An open-label Phase 2 clinical study assessing the efficacy and safety of BCD-248 in adults with relapsed/refractory multiple myeloma; curre…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation [Phase 1]
Phase 1 study evaluating daratumumab in combination with lenalidomide and dexamethasone in Japanese patients with previously untreated multi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
This completed real-world analysis examines patterns of belantamab mafodotin use in patients with relapsed/refractory multiple myeloma and d…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent [Phase 4]
Phase 4 trial assessing DARZALEX (daratumumab) in Indian participants with relapsed and refractory multiple myeloma who had prior proteasome…
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: Multiple Myeloma Patient Registry
A Janssen-sponsored Multiple Myeloma patient registry has been terminated.
-
FDA approval · 2025-01-31FDA Approved: LENALIDOMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's generic lenalidomide (LENALIDOMIDE) under an Original Application (ANDA 216213).
-
CLINICAL_TRIALS withdrawal · 2025-01-31Clinical Trial Update: A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors [Phase 1]
A Phase I trial evaluated the tolerability of 225Ac-DOTATATE in patients with refractory or relapsed multiple myeloma expressing somatostati…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Bendamustine and Melphalan in Myeloma [Phase 2]
Phase 2 trial evaluating bendamustine plus melphalan in multiple myeloma has completed and posted results on 2025-01-30.
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma [Phase 1, Phase 2]
This update describes a Phase Ib/II study evaluating linperlisib in combination with the VRD regimen for newly diagnosed multiple myeloma, w…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The Effect of Self Acupressure Application on Pain, Fatigue and Sleep Quality in Multiple Myeloma Patients [NA]
This clinical trial evaluated self acupressure for pain, fatigue, and sleep quality in patients with multiple myeloma, and the study has com…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating ixazomib citrate and lenalidomide after stem cell transplant in newly diagnosed multiple myeloma has completed and …
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 2]
A Phase 2 study evaluating maintenance belantamab mafodotin after BCMA-directed CAR T-cell therapy in relapsed or refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients [NA]
A terminated clinical trial evaluating acupuncture for chemotherapy-induced peripheral neuropathy in patients with multiple myeloma has post…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML [Phase 1]
The Phase 1 trial of LAVA-051 in relapsed/refractory Chronic Lymphocytic Leukemia, Multiple Myeloma, or Acute Myeloid Leukemia has been term…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab [Phase 2]
An international Phase 2 treatment-extension study of adults with multiple myeloma who have benefited from isatuximab is ongoing (ACTIVE_NOT…
-
EMA approval · 2025-01-22EMA Authorised: Thalidomide BMS (previously Thalidomide Celgene) (thalidomide) — Bristol-Myers Squibb Pharma EEIG
The EMA authorised thalidomide (Bristol-Myers Squibb) for the treatment of multiple myeloma in the EU, with Bristol-Myers Squibb Pharma EEIG…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients [Phase 1]
This document provides an update on a Phase 1 autologous memory-like NK cell therapy trial in multiple myeloma using BHV-1100 with low-dose …
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
A completed clinical trial investigated the role of large extracellular vesicles as biomarkers in various lymphomas and lymphoproliferative …
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors [NA]
A Clinical Trial Update describes a novel CAR-T therapy expressing IL-15 for malignant hematological tumors, with recruitment ongoing and no…
-
CLINICAL_TRIALS withdrawal · 2025-01-17Clinical Trial Update: Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 trial of ISB 1442 for relapsed/refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma
This completed clinical trial update summarizes an assessment of financial difficulty experienced by participants with chronic lymphocytic l…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Immune Profiling in Multiple Myeloma
An update on a study of immune profiling in multiple myeloma, with the trial status shown as completed.